Premium
Medical management of neurotrophic keratitis
Author(s) -
RAMA P.
Publication year - 2017
Publication title -
acta ophthalmologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.534
H-Index - 87
eISSN - 1755-3768
pISSN - 1755-375X
DOI - 10.1111/j.1755-3768.2017.03323
Subject(s) - medicine , disease , perforation , stromal cell , inflammation , neurotrophic factors , intensive care medicine , pathology , immunology , materials science , receptor , punching , metallurgy
Summary Considerations for the medical management of neurotrophic keratopathy ( NK ) depend upon the stage/ severity and pathology of the underlying disease process. Therapeutic approaches are broadly divided into strategic areas that encompass categories of treating the underlying disease process, treating any concurrent infections, preventing disease progression, promoting epithelialisation, providing tear replacement, reducing inflammation, preventing stromal tissue loss or perforation and avoiding complications.